company background image
VBIV

VBI Vaccines NasdaqCM:VBIV Stock Report

Last Price

US$0.46

Market Cap

US$119.2m

7D

-17.2%

1Y

-82.2%

Updated

07 Dec, 2022

Data

Company Financials +
VBIV fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance0/6
Financial Health5/6
Dividends0/6

VBIV Stock Overview

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology.

VBI Vaccines Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for VBI Vaccines
Historical stock prices
Current Share PriceUS$0.46
52 Week HighUS$2.75
52 Week LowUS$0.45
Beta1.67
1 Month Change-27.75%
3 Month Change-47.43%
1 Year Change-82.24%
3 Year Change-47.16%
5 Year Change-88.01%
Change since IPO-97.53%

Recent News & Updates

Recent updates

Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?

Jun 09
Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?

Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?

Jan 24
Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?

Is VBI Vaccines (NASDAQ:VBIV) Weighed On By Its Debt Load?

Oct 06
Is VBI Vaccines (NASDAQ:VBIV) Weighed On By Its Debt Load?

VBI Vaccines (NASDAQ:VBIV) Has Debt But No Earnings; Should You Worry?

Jul 08
VBI Vaccines (NASDAQ:VBIV) Has Debt But No Earnings; Should You Worry?

The CEO Of VBI Vaccines Inc. (NASDAQ:VBIV) Might See A Pay Rise On The Horizon

Jun 03
The CEO Of VBI Vaccines Inc. (NASDAQ:VBIV) Might See A Pay Rise On The Horizon

Market Sentiment Around Loss-Making VBI Vaccines Inc. (NASDAQ:VBIV)

Mar 30
Market Sentiment Around Loss-Making VBI Vaccines Inc. (NASDAQ:VBIV)

The VBI Vaccines (NASDAQ:VBIV) Share Price Has Gained 178%, So Why Not Pay It Some Attention?

Mar 02
The VBI Vaccines (NASDAQ:VBIV) Share Price Has Gained 178%, So Why Not Pay It Some Attention?

Is VBI Vaccines Inc. (NASDAQ:VBIV) Popular Amongst Institutions?

Feb 02
Is VBI Vaccines Inc. (NASDAQ:VBIV) Popular Amongst Institutions?

Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?

Dec 29
Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?

How Much Is VBI Vaccines Inc. (NASDAQ:VBIV) Paying Its CEO?

Dec 01
How Much Is VBI Vaccines Inc. (NASDAQ:VBIV) Paying Its CEO?

Shareholder Returns

VBIVUS BiotechsUS Market
7D-17.2%1.9%-0.4%
1Y-82.2%-11.2%-20.6%

Return vs Industry: VBIV underperformed the US Biotechs industry which returned -6.5% over the past year.

Return vs Market: VBIV underperformed the US Market which returned -17.6% over the past year.

Price Volatility

Is VBIV's price volatile compared to industry and market?
VBIV volatility
VBIV Average Weekly Movement8.6%
Biotechs Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.3%

Stable Share Price: VBIV is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: VBIV's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a152Jeff Baxterhttps://www.vbivaccines.com

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection.

VBI Vaccines Inc. Fundamentals Summary

How do VBI Vaccines's earnings and revenue compare to its market cap?
VBIV fundamental statistics
Market CapUS$119.24m
Earnings (TTM)-US$110.94m
Revenue (TTM)US$870.00k

137.4x

P/S Ratio

-1.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
VBIV income statement (TTM)
RevenueUS$870.00k
Cost of RevenueUS$11.21m
Gross Profit-US$10.34m
Other ExpensesUS$100.61m
Earnings-US$110.94m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.43
Gross Margin-1,188.16%
Net Profit Margin-12,752.30%
Debt/Equity Ratio57.8%

How did VBIV perform over the long term?

See historical performance and comparison